A Prospective, Blinded Assessment of Ammonia Testing Demonstrates Low Utility Among Front-Line Clinicians

Juan J Gonzalez1, Elliot B Tapper2

  • 1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; Division of Hospital Medicine, University of Michigan, Ann Arbor, Michigan.

Insights

Ammonia testing is common for hepatic encephalopathy (HE) but has limitations. More data is needed on why clinicians order these tests to improve quality and reduce overuse.

Area of Science:

  • Hepatology
  • Clinical Chemistry

Background:

  • Ammonia is crucial in hepatic encephalopathy (HE) pathophysiology.
  • Current ammonia testing has diagnostic and technical limitations.
  • Routine ammonia level testing persists despite these issues.

Purpose of the Study:

  • To investigate the reasons, context, and perceived value of ammonia testing among clinicians ordering the tests.
  • To gather data for optimizing quality improvement interventions targeting ammonia test overuse.

Main Methods:

  • The abstract does not specify the methods used.
  • Further research is needed to determine the methodology.

Main Results:

  • The abstract does not specify the results.
  • Data on clinician's reasons for ordering ammonia tests are lacking.

Conclusions:

  • Additional data on the utility and context of ammonia testing are required.
  • Understanding clinician rationale is essential for effective quality improvement initiatives to curb unnecessary testing.